Treatment patterns among Medicare beneficiaries with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2020-2024.
701 Background: Neoadjuvant (NADJ) and adjuvant (ADJ) therapies are recommended to complement RC in MIBC to improve patient outcomes. However, their use decreases with age, and patients (pts) ≥65 y are often underrepresented in clinical trials. This study describes real-world treatment patterns in NADJ and ADJ...